Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,020.00
Bid: 1,955.00
Ask: 2,040.00
Change: 0.00 (0.00%)
Spread: 85.00 (4.348%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,020.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

19 Jun 2013 15:00

RNS Number : 4031H
S & U PLC
19 June 2013
 



19 June 2013

 

S & U PLC ("S&U" or "the Company")

DTR 5.6.1 and Director/PDMR Shareholding

S&U on 18th June 2013 have issued 4,697 ordinary shares of 12.5p each ("Ordinary Shares") in the Company in order to satisfy options issued under the Company's 2008 Discretionary Share Option Plan. On the same date S&U have also issued 10,000 ordinary shares of 12.5p each ("Ordinary Shares") in the Company in order to satisfy options issued under the Company's 2010 Long Term Incentive Plan. Following the issue of these Ordinary Shares the Company has 11,766,425 Ordinary Shares in issue. An application has been made to the London Stock Exchange for these Ordinary Shares to be admitted to trading and admission is expected on 24 June 2013.

 

DISCLOSURE AND TRANSPARENCY RULES DTR 5.6.1 R

There are 200,000 6.0% Cumulative preference shares of £1 each in the Company and 3,598,506 31.5% Cumulative preference shares of 12.5p each in the Company.

S&U does not hold any shares in treasury.

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,766,425, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FSA's Disclosure and Transparency Rules.

Further to this issue, S&U were advised that the following Executive Directors exercised share options and sold Ordinary Shares on 18 June 2013.

 

Chris Redford exercised approved options over 1,995 Ordinary Shares granted in May 2010. He subsequently sold 1,300 Ordinary Shares at a price of 1236p per Ordinary Share. Following this transaction, the beneficial shareholding of Chris Redford is 1,695 Ordinary Shares representing 0.01% of the total voting rights of the Company.

 

Mike Mullins exercised approved options over 2,500 Ordinary Shares granted in May 2010. He subsequently sold 1,100 Ordinary Shares at a price of 1236p per Ordinary Share. Following this transaction, the beneficial shareholding of Mike Mullins is 1,400 Ordinary Shares representing 0.01% of the total voting rights of the Company.

 

Guy Thompson exercised approved options over 202 Ordinary Shares and LTIP options over 10,000 Ordinary Shares, all granted in May 2010. He subsequently sold 10,202 of Ordinary Shares at a price of 1199p per Ordinary Share. Following this transaction, the beneficial shareholding of Guy Thompson is nil Ordinary Shares representing 0% of the total voting rights of the Company.

 

For further information, please contact: 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

Broker and Financial Adviser

Adrian Trimmings/Jamie Cameron Arden Partners 020 7614 5920

 

Media and Investor Relations

Will Swan / Rebecca Hunt Smithfield 020 7360 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLKLFFXQFEBBQ
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.